Menu Back toDay2-Session-4-B

Accelerating Access to Innovative Products – Improving Responses to Pandemic Diseases

Day2: Session 4-B:

Session Chair(s)

Dorothee  Lille ep Grimald, PharmD

Dorothee Lille ep Grimald, PharmD

  • Director, Global Regulatory Policy
  • Merck Sharp and Dohme USA, United States


Lorenz  Scheppler, PhD

D2:S4-B:1.1: Bringing Innovation to Patients – Industry Perspective on Expediting Access

Lorenz Scheppler, PhD

  • Director, Global Regulatory Affairs
  • Janssen Vaccines On Behalf of IFPMA VSRWG, Switzerland
Pamela  Kiu

Pamela Kiu

  • Regulatory Affairds & Quality Assurance Manager Diagnostic Div.
  • Abbott Laboratories SPTE Ltd, Singapore

Contact us